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Cells need to preserve genome integrity despite varying cellular and physical states. p53, the guardian 
of the genome, plays a crucial role in the cellular response to DNA damage by triggering cell cycle arrest, 
apoptosis or senescence. Mutations in p53 or alterations in its regulatory network are major driving 
forces in tumorigenesis. As multiple studies indicate beneficial effects for hyperthermic treatments 
during radiation- or chemotherapy of human cancers, we aimed to understand how p53 dynamics after 
genotoxic stress are modulated by changes in temperature across a physiological relevant range. To 
this end, we employed a combination of time-resolved live-cell microscopy and computational analysis 
techniques to characterise the p53 response in thousands of individual cells. Our results demonstrate 
that p53 dynamics upon ionizing radiation are temperature dependent. In the range of 33 °C to 
39 °C, pulsatile p53 dynamics are modulated in their frequency. Above 40 °C, which corresponds to 
mild hyperthermia in a clinical setting, we observed a reversible phase transition towards sustained 
hyperaccumulation of p53 disrupting its canonical response to DNA double strand breaks. Moreover, 
we provide evidence that mild hyperthermia alone is sufficient to induce a p53 response in the absence 
of genotoxic stress. These insights highlight how the p53-mediated DNA damage response is affected 
by alterations in the physical state of a cell and how this can be exploited by appropriate timing of 
combination therapies to increase the efficiency of cancer treatments.
Preserving genome integrity is a central function of all metazoan cells. Therefore, complex mechanisms evolved 
to detect and respond to DNA damage. However, the underlying molecular networks are subjected to varying 
physical and cellular states that limit their functionality. Among the most basic physical properties that influence 
molecular functions is temperature. Previous studied revealed that some cellular networks such as circadian 
clocks are compensated towards changes in temperatures1, while others such as the NF-kB-mediated response to 
inflammatory cytokines show temperature-dependent changes in their dynamics2. To determine to which extent 
temperature affects the cellular capacity to preserve genome integrity, we focused on the molecular network con-
trolling the tumour suppressor p53.
The transcription factor p53 is activated by cellular stresses such as DNA damage and activates the expression 
of downstream genes that mediate cellular responses ranging from transient cell cycle arrest and damage repair 
to terminal cell fates such as senescence or apoptosis3,4. In unstressed cells, p53 protein is kept at low levels by 
Mdm2 - mediated ubiquitination and subsequent proteasomal degradation5. Posttranslational modifications by 
DNA damage-activated kinases such as ATM and ATR disrupt this interaction and lead to p53 stabilization and 
accumulation in the nucleus. P53-mediated signalling is a highly dynamic process that integrates information 
from various sources to regulate the cellular stress response6,7. Therefore, the temporal pattern of p53 accumula-
tion correlates with the type and quantity of the stimulus8. Ionizing radiation (IR) induces uniform pulses of p53 
accumulation with comparable amplitude and duration9,10. The number of pulses is positively correlated with the 
damage dose11. These pulsatile p53 dynamics are triggered by negative feedback loops within the p53 signalling 
network, mainly through the ubiquitin ligases Mdm2 and the phosphatase PPM1D/Wip19,12,13. In contrast, p53 
exhibits only a single sustained pulse with dose-dependent amplitude and duration in response to ultraviolet 
(UV) radiation8. Using pharmacological and genetic perturbation, we have previously shown that p53 dynamics 
contribute to cell fate choices post damage14,15. In most human cancers, p53 is inactivated either directly by muta-
tions that compromise the stability of the protein or its ability to bind DNA, or indirectly by amplifications of its 
negative regulators such as Mdm2 or Wip116. Inactivation of p53 correlates with increased resistance to therapy 
and poor survival17.
As homoeothermic organisms, humans maintain a stable core body temperature of about 37 °C at rest. 
However, body temperature at the periphery and specifically at the extremities drops significantly to 33 °C or 
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lower, depending on ambient temperatures18,19. Other factors such as age, time of day, sex, reproductive status and 
activity level lead to deviating body temperatures as well20,21. Moreover, during physical exertion, the physiologi-
cal range of core temperatures extends beyond 40 °C22. Even higher core temperatures are observed in pathologi-
cal settings such as vascular disease where the transport of blood and heat is perturbed, or during fever, which is 
associated with several different diseases including infections, autoimmune diseases23 and cancer24.
Changes in temperature affect organisms on multiple levels. Its direct impact on enzyme-catalysed reactions 
is characterized by the Arrhenius equation, which describes that reaction velocities double when temperature 
increases by 10 °C until they abruptly decline due to protein denaturation25. On the cellular level, temperature 
changes affect metabolism, protein synthesis and cell cycle regulation26. Hyperthermia, in particular, causes 
membrane, DNA and protein damage and influences cell fate by triggering cell cycle arrest, senescence, apoptosis, 
or necrotic cell death27–31. On the organismic level, studies indicate that deviations in core temperature of more 
than 4 °C can result in physiological impairments and fatality32.
Previous studies investigating the effect of temperature changes on the DNA damage response (DDR) mainly 
focused on the damage-activated kinases ATM and ATR and their downstream effectors Chk1 and Chk2, which 
orchestrate a network of cellular processes to maintain genomic integrity33. It has been observed that hyperther-
mia leads to activation of human ATR inducing cell-cycle arrest at the G2/M transition34. Furthermore, activated 
ATR may help to stabilize arrested replication forks preventing accumulation of chromosomal lesions35. Similarly, 
hyperthermia induces auto-phosphorylation and activation of ATM36, which is however delayed by 1–2 hours 
compared to ATR activation34. Interestingly, other components of the DDR are inhibited at high temperatures: 
the Mre11-Rad50-Nbs1 (MRN) complex, which is essential for ATM activation by DNA double strand breaks 
(DSBs), translocates from the nucleus to the cytosol at high temperatures37 and the binding of 53BP1 to chroma-
tin around DSBs is prevented36,38, restricting the capacity of ATM to sense this form of DNA damage.
Clinically, the application of exogenous heat in combination with canonical anti-cancer treatments is an estab-
lished therapeutic strategy against various human tumours39. Several randomized trials have demonstrated the 
benefits of hyperthermia (40–42 °C for at least 1 hour) combined with radiotherapy or chemotherapy with regard 
to local tumour control and survival40–42. Hyperthermia also amplifies the therapeutic effect of chemotherapy43–46. 
Pre-clinical and clinical studies suggest that hyperthermia is effective both in cancers with wild-type p53 and 
those without active p53. To our knowledge, the p53 status of cancers being treated with hyperthermia is not 
routinely determined in the clinic47,48. Molecularly, it was shown that cancer cells get arrested in different stages of 
the cell cycle (S/G2 or G2/M) and lose the ability to repair chromosomal lesions, which promotes cell death34,49–51.
In response to temperature changes, a family of heat shock factors (HSF1-4) initiates the expression of heat 
shock proteins (HSP). The most well-known family member is HSF1, which is constitutively expressed and reg-
ulates the expression of HSP as well as other genes related to cell signalling, cell integrity, development, growth, 
fertility, senescence and apoptosis52–54. HSF1 has been reported to interact at different levels with the p53 network 
by supporting post-translational modifications and acting as a transcriptional co-factor55. Furthermore, interac-
tion of the HSF1 target Hsp90 with p53 prevents Mdm2 mediated ubiquitination56 and modulates its binding to 
the CDKN1A/p21 promotor55. Additional heat shock proteins such as Hsp70 and Hsp40 are as well capable of 
stabilizing p53-DNA complexes57,58.
We now aimed to systematically study how temperature affects p53 signalling. Is the molecular network con-
trolling activation of the main human tumour suppressor compensated against changes in temperature or does 
its response to DNA damage dependent on the physical environment? To address this question, we employed an 
established fluorescent reporter cell line59 and followed the dynamics of p53 accumulation after ionizing radiation 
at the single cell level using time-resolved live-cell microscopy. Computer-aided image and data analysis indicated 
that the dynamic features of the pulsatile p53 response vary with temperature within the range of 33 °C to 39 °C. 
Above 40 °C, we observed a reversible phase transition to fundamentally different p53 accumulation dynamics, 
which may provide new insights how hyperthermia can be used to improve cancer therapy.
Results
P53 dynamics upon genotoxic stress are temperature dependent. To monitor p53 dynamics, we 
employed a clonal A549 lung carcinoma cell line stably expressing p53 fused to the yellow fluorescent protein 
mVenus and the nuclear marker H2B fused to a cyan fluorescent protein (mCerulean) (Fig. 1A)59. We irradiated 
cells with 10 Gy X-ray (250 kV) and monitored their p53 protein levels for 24 h by time-resolved live-cell micros-
copy. As previously described, p53 protein accumulated in a pulsatile manner upon damage induction (Fig. 1B)8. 
Using computer-aided image analysis, we followed thousands of individual cells and quantified their p53 response 
(see methods sections for details). Trajectories of individual cells confirmed uniform pulsatile p53 dynamics upon 
damage induction (Fig. 1C) that were asynchronous and heterogeneous across the population (Fig. 1D). This led 
to the appearance of damped pulses in the median p53 level of cell populations (Fig. 1E)60.
To investigate the influence of varying temperature on the p53 response to genotoxic stress, we equilibrated 
cells to temperatures ranging from 33 °C to 41 °C for 14 h and performed time-lapse microscopy of untreated and 
irradiated cells at the respective temperatures (Fig. 2A–E). To compare p53 dynamics from different microscopy 
experiments, we normalized the resulting data under the assumption of equal initial p53 distributions (Supp. 
Fig. S1, see methods for details). When lowering temperature, we monitored an increased duration of p53 pulses 
and a reduced frequency in the median trajectories of corresponding populations (Fig. 2A–B) compared to cells 
damaged at 37 °C (Fig. 2C, Supp. Fig. S2A,B and Supp. Movies S1–6). Untreated cells did not show noticea-
ble changes in p53 levels at 33 °C or 35 °C (Supp. Fig. S2E,F). When we increased the temperature to 39 °C, we 
could observe the opposite effect: pulse duration decreased and pulses appeared to happen faster (Fig. 2D, Supp. 
Fig. S2C and Supp. Movies 7 and 8). Interestingly, even untreated cells showed minor increases in p53 levels dur-
ing time-lapse microscopy (Fig. 2D, black line/shaded area and Supp. Fig. S2G). Finally, when we increased tem-
perature to 41 °C, which corresponds to mild hyperthermia in a clinical setting, we found a striking change in p53 
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dynamics: instead of regular pulses of p53 accumulation, we now observed a single sustained p53 pulse of long 
duration after damage induction (Fig. 2E, Supp. Fig. S2D,I and Supp. Movies S9 and 10). The maximum increase 
in the p53 level was about 1.5 fold higher than the average amplitude of the first pulse at 37 °C. Even in the absence 
of damage induction, p53 levels strongly accumulated in the nucleus during the observation period (Fig. 2E, black 
line/shaded area and Supp. Fig. 2H,I), reaching around 60% of the average amplitude of the first pulse at 37 °C.
When we analysed how untreated cells proliferated at different temperatures, we observed decreased prolif-
eration rates below and above normothermia as expected (Fig. 2F). At 41 °C, most cells stopped dividing. Upon 
irradiation, cells remained arrested for the duration of the experiment at all temperatures tested (Fig. 2G). In 
addition to changes in dynamics and proliferation, we also observed a strong increase in heterogeneity when 
moving from 39 °C to 41 °C both in treated and untreated cells (Fig. 2H,I). Similar results were observed in the 
non-transformed diploid breast epithelial cell line MCF10A expressing p53 fused to mVenus from the endoge-
nous gene locus (Supp. Fig. S3)61. Interestingly, MCF10A cells tended to show sustained p53 accumulation already 
at 39 °C.
As we were surprised by the strong response of untreated cells at 41 °C despite equilibrating cells to the higher 
temperature, we compared the p53 response in cells pre-equilibrated to 41 °C with cells that were acutely shifted 
to the higher temperature at the beginning of the experiment. (Fig. 2J). In pre-equilibrated cells, we observed a 
fast and strong increase of the nuclear p53 level upon damage, reaching a maximum around 8 h after the stimulus. 
Afterwards, p53 levels declined until the end of the observation period (Fig. 2E). p53 levels in non-irradiated cells 
increased more slowly and reached a plateau at about 60% of the peak p53 levels after irradiation. In cells directly 
exposed to 41 °C, nuclear p53 accumulated faster upon damage induction, reaching peak-levels already 4 h post 
irradiation. P53 levels than decayed quickly during the remaining 20 h (Fig. 2J). Non-irradiated cells showed a 
similarly strong increase upon the temperature shift, reaching around 85% of peak levels in damaged cells after 
6 h. Interestingly, p53 levels then declined slower than in irradiated cells, which led to on average higher p53 levels 
in non-treated cells compared to damaged cells (Fig. 2J).
To further compare the strength of the p53 response at different temperatures and treatment conditions, we 
quantified the integrated nuclear level of p53 for the observation period. Over the temperature range from 33 °C 
to 39 °C, cumulative p53 levels remained similar in undamaged cells and upon irradiation (Fig. 2K). At 41 °C, 
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Figure 1. p53 dynamics in individual cells (A) Schematic overview of the reporter system used to monitor p53 
dynamics. P53 fused to the yellow fluorescent protein mVenus (YFP) is stably expressed under control of the 
EF1A promoter. H2B is fused to mCerulean (CFP) to track nuclei in time-lapse microscopy images. (B) Time-
lapse microscopy images of a selected cell irradiated with 10 Gy. The marker H2B-CFP is shown in red, p53-YFP 
in green. (C) Median nuclear p53-YFP levels were quantified over time for the cell shown in (B). (D) P53 levels 
were quantified in thousands of cells. To demonstrate the heterogeneity of the response, 20 randomly picked 
trajectories of p53 levels after 10 Gy ionizing radiation were visualized. (E) The p53 response on the population 
level at 37° (black: non-irradiated control cells; blue: cells irradiated with 10 Gy). Bold lines indicate median p53 
levels, shaded areas reflect the inter-quantile range between the 0.25 and 0.75 quantile. See Table S1 for number 
of analysed cells.
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median integrated p53 levels of non-irradiated pre-equilibrated cells were comparable to those of damaged cells 
at lower temperature, although we observed a wider distribution across the population. Cells irradiated at 41 °C 
showed similar cumulative p53 levels, no matter whether they were pre-equilibrated or acutely shifted to the 
higher temperature, despite diverging dynamics. Strikingly, non-irradiated cells acutely exposed to 41 °C showed 
on average the strongest p53 response. The differences between cells pre-equilibrated at or directly exposed to 
41 °C point to a decreased sensitivity to hyperthermia of pre-equilibrated cells.
Pulsatile p53 dynamics are disrupted at 41 °C. To get a better understanding of the temperature 
dependence of p53 dynamics at the single cell level, we employed the Average Magnitude Difference Function 
(AMDF)62 to estimate the pitch of p53 pulses in single cell trajectories. The positions of the first 3 pulses varied 
substantially between the different temperatures (Fig. 3A). At 33 °C, the first p53 peak occurred on average 1.5 h 
later than at 37 °C. Conversely, cells at 39 °C responded on average faster than cells at 37 °C, although distributions 
of first pitch positions overlapped in the range from 35 °C to 39 °C. We measured the same trend for the 2nd and 3rd 
pulse (Fig. 3A). Furthermore, we observed an increase in the variability of the pitch position with increasing tem-
perature. Temperature-dependent changes in pulse timing and synchrony led to decreasing median inter-pulse 
intervals at increasing temperature while the width of the corresponding distributions increased (Fig. 3B). An 
alternative way to visualize pulsatile p53 dynamics is to plot auto-correlation coefficients of nuclear p53 levels 
at different time points across populations of cells. The resulting heatmaps clearly show temperature-dependent 
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Figure 2. p53 dynamics are temperature sensitive (A–E) Population level p53 responses of pre-equilibrated 
cells for the temperature range from 33 °C to 41 °C (black: non-irradiated, blue: 10 Gy IR). Bold lines indicate 
median p53 levels, shaded areas reflect the inter-quantile ranges from 0.25 to 0.75. At 41 °C, p53 dynamics 
change dramatically, as pulsatile p53 accumulation gets supplanted by a strong sustained response. See Table S1 
for number of analysed cells. (F–G) Cell proliferation shown as number of cell divisions per cell within 24 h 
for non-irradiated (F) and irradiated (G) cells incubated at the indicated temperatures. (H–I) Coefficients 
of variation over time for control (H) or damaged (I) cell populations shown in (A–E). At 41 °C, we detected 
strong increases in heterogeneity for both conditions. At other temperatures heterogeneity was mainly caused 
by increasing asynchrony of p53 pulses within a population. (J) p53 response of control and irradiated cell 
populations acutely shifted to 41 °C without prior pre-equilibration. The responses differ in amplitude and 
dynamics from our observations in (E). See Table S1 for number of analysed cells. (K) Accumulated p53 levels 
for non-irradiated and irradiated cells over the temperature range from 33 °C to 41 °C for the observation period 
of 24 h (left). Estimated changes compared to cells incubated at 37 °C are indicated on the right (red dots); error 
bars represent 95% confidence intervals determined by permutation testing. Dashed lines serve as guides to the 
eye.
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Figure 3. Quantification of dynamic features of the p53 response (A) Quantification of the first 3 pitch 
positions estimated by the average magnitude difference function for irradiated cells (10 Gy) over a temperature 
range from 33 °C to 37 °C. Red lines indicate medians of distributions; boxes include data between the 25th and 
75th percentiles; whiskers extend to maximum values within 1.5 × the interquartile range. Estimated changes 
compared to cells incubated at 37 °C are indicated below (red dots); error bars represent 95% confidence 
intervals determined by permutation testing. Dashed lines serve as guides to the eye. (B) Quantification of 
the inter-pitch intervals for irradiated cells (10 Gy) over a temperature range from 33 °C to 37 °C. With lower 
temperatures the length of the interval increases while the range of the distribution is reduced. Estimated 
changes compared to cells incubated at 37 °C are indicated below (red dots); error bars represent 95% 
confidence intervals determined by permutation testing. Dashed lines serve as guides to the eye. (C) Auto-
correlation among irradiated cells at 37 °C and 41 °C. Each point in this graph represents the correlation 
coefficient between p53 levels in the population at two different time points, except along the main-diagonal. 
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changes of the regular p53 accumulation in the range from 33 °C to 39 °C (Fig. 3C, left and Supp. Fig. 4). In con-
trast, no periodicity was observable in cells damaged at 41 °C (Fig. 3C, right). Instead, the p53 response was cor-
related over extended periods of times, indicating that cells with a strong immediate response also reacted more 
strongly at later time points compared to cells with a weaker early response.
A good measure to quantify temperature sensitivity is the Q10 temperature coefficient1, which reflects the rate 
of change of biological systems when temperature is raised by 10 °C assuming that reaction rates depend expo-
nentially on temperature. For the p53 system, we determined a Q10 coefficient of 1.53 ± 0.24 based on the position 
of the 3rd pitch, which is on the lower end of coefficients usually observed in biology (Q10 ~ 2-3)63.
As autocorrelation-based pitch detection is designed to recognize repeating patterns across the entire tra-
jectory, we employed a feature detection approach based on local dynamic time warping64 inspired by the 
Smith-Waterman algorithm65 to characterized individual p53 pulses (Supp. Fig. S5A–C, see methods for details). 
We first determined probabilities for detecting a certain feature at a given time point in individual trajectories 
and again observed temperature-dependent changes in timing from 33 °C to 39 °C as expected (Fig. 3D and 
Supp. Fig. S5D–G). At 41 °C, pulsatile dynamics broke down and we observed only one extended feature in most 
cells (Fig. 3D and Supp. S5H). In addition to changes in pulse frequency, this analysis also confirmed changes in 
synchrony of features with temperature. We observed a similar dependency of dynamic features on temperature 
in MCF10A cells, although they showed widespread break down of pulsatile dynamics already at 39 °C (Supp. 
Fig. S5I). We next analysed the length of the first three pulses in A549 cells. The length of the first pulse increased 
from about 4.5 h to 6.5 h as the temperature was lowered from 37 °C to 33 °C (Fig. 3E). Subsequent pulses are in 
general shorter, however, median durations again increased with lower temperatures. At 39 °C, the average length 
of later pulses was similar to 37 °C, although the distributions were markedly wider. Pulse amplitudes defined as 
the difference between maximal and minimal p53 levels within a pulse were damped for the first pulse at tem-
peratures below 37 °C (Fig. 3F). At 39 °C, they remained equal to normothermia. Interestingly, these differences 
diminished for later pulses.
As previous reports have shown that p53 dynamics affect the cellular outcome of the DNA dam-
age response14,66, we aimed to determine if the expression of p53 target genes upon damage induction is 
temperature-dependent as well. To this end, we focused on a set of high-confidence target genes that contribute 
to distinct cellular response pathways, including CDKN1A/p21, GADD45 (both cell cycle arrest), XPC (DNA 
damage repair) and BAX (apoptosis), and measured corresponding RNA levels at different time points and tem-
peratures in untreated and irradiated cells by qPCR3. For p21, GADD45 and, to a lesser extent, XPC, we observed 
increased expression at lower temperatures (35 °C) when p53 showed longer and less frequent accumulation 
pulses (Supp. Fig. S6A–D). However, these target genes were also affected by temperature shifts alone, indicating 
a combined effect of altered p53 dynamics and temperature-induced changes in gene expression. Interestingly, 
we observed increased expression of BAX at higher temperatures (39 °C) at late time points post damage, sug-
gesting an increased tendency to induce apoptosis under these conditions. At 41 °C, expression of CDKN1A and 
GADD45 was attenuated, while expression of BAX and XPC was slightly increased, following the trends observed 
at 39 °C (Supp. Fig. S6E–H). We also detected less cells arrested in G2 24 h and 48 h after irradiation at 41 °C as 
well as a slight increase in apoptotic cells (Supp. Fig S6I,J).
In MCF10A cells, which express p21 protein tagged with the red fluorescent protein mCherry from the endog-
enous locus as well, we similarly observed that the immediate p21 response at about 8 h was strongest at 33 °C and 
decreased in amplitude with increasing temperature (Supp. Fig. S3E–H). Interestingly, the sustained accumula-
tion of p21 at later time periods between 12 h and 24 h was most pronounced at 37 °C.
An ongoing p53 response is modulated by changes in temperature. As we observed a strong 
temperature-dependency of p53 dynamics when we irradiated cells at different temperatures, we next inves-
tigated how dynamic features are affected by temperature changes during an ongoing response to genotoxic 
stress. To this end, we equilibrated cells at 37 °C, performed time-lapse microscopy upon irradiation with 10 Gy 
X-ray and altered temperature in a range from 33 to 41 °C at 12 h approximately after the 3rd p53 pulse (Fig. 4A). 
Even though p53 was already accumulating in a regular pulsatile manner, lowering temperature led to a reduced 
frequency of p53 pulses, as indicated by feature analysis starting from the time of temperature shifts (Fig. 4B). 
Correspondingly, increasing temperature to 39 °C increased pulse frequency as well as heterogeneity. Shifting 
cells to 41 °C induced a strong immediate but transient p53 response without further pulsing.
The observed immediate effects of temperatures changes on p53 dynamics prompted us to further investi-
gate p53 induction by hyperthermia alone. We were specifically puzzled by the increased p53 levels observed in 
non-damaged cells pre-equilibrated to 41 °C. We hypothesized that short-term temperature changes during irra-
diation were sufficient to reset the state of the p53 system by inducing re-folding of the protein, reverting potential 
interactions with HSPs and inducing re-expression of Mdm2. To test this hypothesis, we equilibrated cells to a 
temperature of 41 °C and performed time-lapse microscopy of untreated and irradiated cells. The temperature 
We detected repetitive pulses for 37 °C, but only one long homogenous response for 41 °C. (D) Probabilities 
of being in a certain pulse state at a given time point for irradiated cells (10 Gy) over a temperature range from 
33 °C to 41 °C. Pulses are detected using a local dynamic time warping based approach. The pulsing frequency 
is positively correlated with the temperature within the range between 33 °C to 39 °C. At 41 °C the pulsing 
dynamics is completely lost and replaced by a sustained response. (E–F) Quantification the duration (E) and 
amplitude (F) of the first 3 pulses with respect to temperature. Estimated changes compared to cells incubated at 
37 °C are indicated below (red dots); error bars represent 95% confidence intervals determined by permutation 
testing. Dashed lines serve as guides to the eye.
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was kept at 41 °C for the first 6 h and afterwards decreased to normothermia at 37 °C. This drop in temperature 
took around 30 minutes due to the technical capabilities of our incubation system. As previously observed, irra-
diated and untreated cells responded with a strong initial p53 response to hyperthermia conditions. However, 
as soon as the temperature change back to normothermia was initiated, p53 levels decreased and irradiated cells 
started to show pulsatile dynamics at about 9 h post damage (Fig. 5A, upper graph). Surprisingly, we also detected 
pulses in non-irradiated cells after the p53 response to hyperthermia decayed. Non-treated cells stopped prolif-
eration at 41 °C (Fig. 5A, lower graph). However, they continued to divide soon after the return to normothermia 
with similar rates as cells incubated continuously at 37 °C. Irradiated cells remained arrested for 48 h independent 
of the temperature.
To quantify the observed pulses after transient temperature shifts, we applied our feature detection approach. 
As expected, the immediate response to hyperthermia was similar in amplitude to previously observations. 
Interestingly, the later p53 accumulation pulses were of comparable amplitude in both irradiated and undamaged 
cells (Fig. 5B). However, the timing and synchrony of p53 pulses differed substantially (Fig. 5C–E). In irradiated 
cells, we observed similar relatively homogeneous dynamic patterns as in irradiated cells constantly incubated at 
37 °C. In contrast, the p53 response induced by hyperthermia alone was more heterogeneous, with delayed and 
asynchronous occurrence of p53 peaks, arguing for a different molecular mechanism controlling p53 accumula-
tion in the absence of radiation-induced kinase activity.
Discussion
Reliable information processing by the p53 pathway is crucial to ensure an appropriate cellular response to gen-
otoxic stress in a dynamically changing environment. Perturbation of p53 signalling leads to transformation 
of individual cells and subsequent tumorigenesis. To understand the influence of varying temperature on the 
dynamics of the p53 network upon ionizing radiation, we monitored p53 protein levels of thousands of genetically 
identical cells exposed to the physiologically relevant temperature range of 33 °C to 41 °C. Using a combined com-
putational and experimental single cell approach we have shown that the frequency of p53 accumulation pulses 
that encode DNA damage is positively correlated with temperatures up to 39 °C. Interestingly, heterogeneity of 
p53 dynamics increased with temperature as well. These results highlight that despite its importance for maintain-
ing genome stability, the p53 network is not temperature-compensated at the level of p53 accumulation dynamics. 
Similar observations have been recently reported for the NF-kB network2. Here, information is encoded in oscil-
lations of cytoplasmic to nuclear translocation of the transcription factor RelA, which also increase in frequency 
with temperature. It was shown that temperature-dependent pathway dynamics are caused by differential timing 
of feedback expression and affected only a subset of target genes at early time points. Further investigations will 
show if similar principles are applicable to p53 signalling as well or if the observed changes reflect an integrated 
property of the entire network. Interestingly, we also observed that temperature dependent changes in target gene 
expression were mainly restricted to early time points after damage induction, which may suggest that over longer 
time periods, temperature compensation is achieved at the level of target genes.
To our surprise, we observed a phase transition at 41 °C from canonical pulsatile dynamic to a strong initial 
response followed by sustained nuclear p53 levels, which was reversible upon return to normothermia. A sim-
ilar p53 response was detected in non-irradiated cells exposed to mild hyperthermia. Interestingly, reversion 
of non-irradiated cells to normothermia induced heterogeneous but sustained p53 pulsing for several hours. 
The molecular mechanism of this phase transition is so far unknown. We speculate that it is based on structural 
properties of p53 and Mdm2 as well as their interaction with HSPs. It is well documented that p53 folding is 
marginally stable at physiological temperature. This is highlighted by cancer-related p53 mutants that often show 
temperature-sensitive phenotypes67,68. Unfolding of a substantial fraction of p53 molecules at 41 °C could prevent 










































Figure 4. An ongoing p53 response is altered by changes in temperature (A) Temperature change alters the 
dynamics of an ongoing p53 response. Cells were incubated at 37 °C and exposed to genotoxic stress (10 Gy IR). 
12 h after damage induction, approximately after the 3rd pulse of the expected canonical response, we altered the 
temperature in the range from 33 °C to 41 °C and followed cells for an additional 36 h. Median p53 levels of cell 
populations are indicated. See Table S1 for number of analysed cells. (B) Probabilities of being in a certain pulse 
after temperature change at 12 h.
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their interaction with Mdm2 and subsequent proteasomal degradation. Unfolded p53 would be transcription-
ally inactive, breaking the feedback loop that restricts the duration of the p53 response under normothermic 
conditions. Furthermore, increased levels of Hsp90 upon hyperthermia may contribute to p53 stabilization, 
as the chaperon stabilize p53 conformations that oppose Mdm2 binding, and aids Mdm2 degradation57,69,70. 
Interestingly, cells that were pre-incubated at 41 °C showed a reduced p53 response to hyperthermia, indicating 
that p53 signalling acquires tolerance to heat shocks. The underlying mechanisms and the role of the HSF-HSP 
system will have to be clarified in further studies.
What are the physiological consequences of the observed temperature-dependent p53 dynamics upon gen-
otoxic stress? Due to its central importance for guarding genomic integrity, appropriate p53 function must be 
ensured across physiological temperature ranges. Prolonged p53 accumulation pulses during hypothermia may 
contribute to counteract generally decreased synthesis rates and ensure sufficient expression of crucial target 
genes such as p21. In this way, p53 function rather than its dynamics would be temperature compensated, similar 
to the NF-kB system2. Sustained p53 accumulation during hyperthermia may serve a different purpose. It is well 
known that hyperthermia leads to mitotic phenotypes and genomic instability71 as well as an attenuated damage 
response35. Sustained but reversible p53 accumulation may therefore ensure that cells induce transient cell cycle 
arrest during hyperthermia and only enter mitosis if physical conditions are permissive.



































































































































Figure 5. The p53 response to hyperthermia is reversible (A) Cells pre-equilibrated at 41 °C (see Fig. 2) were 
tracked for 48 h. After 6 h, temperature was reduced to 37 °C. We observed immediate decreases in p53 levels 
followed by pulsatile dynamics. Median p53 levels of cell populations are indicated. See Table S1 for number 
of analysed cells. The lower graph indicates corresponding cumulative fractions of cells dividing over time. 
(B) Quantification of amplitudes for the first 6 pulses detected by the dynamic time warping approach for cell 
populations shown in (A). The first feature corresponds to the acute p53 response to hyperthermia. Subsequent 
pulses mainly detected after reducing the temperature do not differ among irradiated (open boxes) and non-
irradiated cells (solid boxes). Red lines indicate medians of distributions; boxes include data between the 25th 
and 75th percentiles; whiskers extend to maximum values within 1.5 × the interquartile range. Estimated 
changes between irradiated and non-irradiated cells are indicated below (red dots); error bars represent 
95% confidence intervals determined by permutation testing. Dashed lines serve as guides to the eye. (C–D) 
Heatmap of normalized p53 levels for the non-irradiated (C) and irradiated (D) cell population sorted by the 
position of the first new feature appearing after the temperature was set to 37 °C (6 h). The data shown was 
adjusted using images processing techniques to enhance visualization of pulsatile dynamics (see methods 
section). (E) Probabilities of being in a certain feature at a given time point for irradiated and non-irradiated 
cells. The induced pulsing is less heterogeneous for irradiated cells. Non-irradiated cells have on average less 
pulses.
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In the last decades, hyperthermia in combination with radio- and/or chemotherapy has proven to be bene-
ficial for the treatment of human cancers and has gained particular attention due to negligible side effects72,73. 
How hyperthermia influences the outcome of cancer treatment on the molecular level by modulating cellular 
and molecular pathways is not well examined and remains an open question47. Some studies using tissue culture 
and animal models suggest that wild-type p53 may positively affect the efficiency of combined treatments with 
radiation and hyperthermia. In addition, some clinical studies indicate that the p53 status of a tumour may be an 
important predictor for the success of hyperthermia-based therapies48,74. Other studies indicate that apoptosis 
rate rather than p53 status is the better predictor of clinical outcomes47,75. In this regard, the molecular insights 
obtained in our study remain inconclusive: while transient induction of cell cycle arrest protects actively cycling 
cells from entering mitosis at non-permissive temperatures, which would otherwise lead to effective cell killing 
through mitotic catastrophe, the observed hyperaccumulation at temperatures above 41 °C degrees suggests that 
p53 wild-type cancer cells may be susceptible to increased induction of apoptosis or senescence under these con-
ditions. This would be specifically important in situations where p53 function is disabled through amplification 
of its negative regulator Mdm2, as often observed in sarcomas76,77. Moreover, the diverse functions of Hsp90 in 
the p53 network may contribute to positive effects in cancer treatment: Hsp90 accumulated during hyperthermia 
may promote refolding of destabilized mutant p53 upon return to normothermia, compensating functional defi-
ciencies in cancer cells. It will be interesting to determine the dynamics of mutant p53 in response to irradiation 
at different temperatures in future studies and systematically compare the outcome of combined treatments in 
cells with and without active p53. In any case, the observed immediate and reversible effects of hyperthermia on 
p53 dynamics as well as the adaptation of the p53 signalling network to heat exposure provide molecular evidence 
that the precise timing of radiation and hyperthermic treatments is a critical parameter for successful combina-
tion therapies78,79. Further studies using our combined computational and experimental single cell approach will 
allow us to gain a deeper understanding of how varying physical and cellular states affect the function of the p53 
network and how we can exploit this to devise more efficient tumour therapies.
Material and Methods
Cells. The human lung carcinoma cell line A549 expressing p53-mVenus has been described before59. In brief, 
it expresses a p53 cDNA fused to the mVenus coding sequence under the control of the human EF1A promoter as 
well as a histone H2B cDNA fused to the mCerulean coding sequence under the control of the human Ubiquitin 
C promoter. We maintained these cells in McCoy’s 5 A (GE Healthcare Life Sciences, Freiburg, Germany) supple-
mented with 10% fetal calf serum (FCS; Thermo Fisher Scientific, Darmstadt, Germany) as well as penicillin and 
streptomycin. The selective antibiotics G418 (400 μg/ml, Carl Roth, Karlsruhe, Germany) and hygromycin (50 μg/
ml, Thermo Fisher Scientific, Darmstadt, Germany) were added to maintain transgene expression.
The female human non-transformed breast epithelial cell line MCF10A expressing p53-mVenus and 
p21-mCherry has been described before61. In brief, the coding sequence for fluorescent proteins was inserted in 
the endogenous gene loci using Cas9-mediated genome engineering. The chromatin associated protein Cbx5 was 
tagged with mCerulean to serve as a nuclear marker. Cells were maintained in DMEM/F12 with 5% horse serum, 
20 ng/ml EGF, 0.5 mg/ml hydrocortisone, 100 mg/ml cholera toxin and 10 mg/ml insulin. All media contained 
2 mM Glutamax, 100 U/ml penicillin and 100 mg/ml streptomycin. All cell lines were cultures at 37 °C with 5% 
CO2 at saturated humidity if not indicated otherwise.
Time-lapse microscopy. We seeded 1 × 105 cells in ibiTreat polymer-bottom plates (ibidi, Martinsried, 
Germany) 2 d before experiments. When indicated, cells where equilibrated at the given temperature for 14 h. 
The day of the experiment, medium was replaced by FluoroBrite medium (Thermo Fisher Scientific, Darmstadt, 
Germany) lacking phenol red and riboflavin. Cells were treated with X-ray irradiation at a dose rate of 1 Gy/26 s 
(250 KeV, 10 mA). We imaged cells on a Nikon Ti inverted fluorescence microscope (Nikon, Düsseldorf, 
Germany) with a Nikon DS‐Qi2 camera and a 20 × Plan Apo objective (numerical aperture 0.75) using appropri-
ate filter sets (Venus: 500/20-nm excitation [EX], 515-nm dichroic beam splitter [BS], 535/30-nm emission [EM]; 
CFP: 436/20-nm EM, 455-nm BS, 480/40-nm EX). The microscope was enclosed with an incubation chamber 
set to temperatures in the range from 33 °C to 41 °C as indicated. The atmosphere was maintained at 5% CO2 
concentration and saturated humidity. Cells were imaged every 15 min for the duration of the experiment using 
Nikon Elements software59.
Image analysis and cell tracking. Cells were tracked throughout the duration of the experiment using 
custom‐written MATLAB (MathWorks) scripts based on code developed by the Alon laboratory80 and the 
CellProfiler project81. In brief, we applied flat field correction and background subtraction to raw images before 
segmenting individual nuclei from nuclear marker images using thresholding and seeded watershed algorithms. 
Segmented cells were then assigned to corresponding cells in following images using a greedy match algorithm. 
Only cells tracked from the first to last time point were considered. For the analyses we tracked cells in forward 
direction from the first to the last time point. Upon division, we followed the daughter cell closest to the last 
position of the mother and merged tracks from mothers and offspring. Using binary masks from nuclear marker 
images, we quantified mean nuclear fluorescence intensity in the p53/mVenus channel.
Data pre-processing. Before analysis, we pre-processed our data with custom made filters to remove tech-
nical noise and signals from biological events unrelated to the induced response. To remove spikes and sustained 
intensity shifts caused by segmentation and tracking errors, we identified those features based on cell specific 
thresholds defined by the standard deviation of the processed trajectory and replaced them by linear interpola-
tion. Spikes and sustained shifts were defined either by a decrease followed by an increase or an increase followed 
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by a decrease both greater than the standard deviation of the processed trajectory. Removal of spikes and sus-
tained shifts was done iteratively. This led to an increased signal-to-noise ratio due to local smoothing, emphasiz-
ing slower changing biological responses. As the nuclear envelop breaks down during mitosis and morphological 
changes lead to increased auto-fluorescence, we disregarded signals measured during cell division and removed 
them from the trajectories by interpolation. To identify cell division, we normalized for each cell the nuclear area 
and the integrated fluorescence intensity of the nuclear marker to their respective means, smoothed them by the 
approach described above and combined the two trajectories by averaging. We then applied a 1D Prewitt filter 
(length 75 minutes) to the combined trajectory to amplify signal discontinuities that correspond to cell divisions. 
Cell divisions events corresponded to a value of the Prewitt filtered trajectory exceeding a manually selected 
threshold based on several hundred visually detected cell divisions82.
Normalization. Combining different time-lapse microscopy experiments is non-trivial due to multiple sources 
of variability that result in different distributions of the fluorescence intensity measured even among identical exper-
imental settings. These comprise biological sources such as different passage numbers of cell lines uses as well as 
technical sources such as different light sources. To overcome the limitations of comparing different experiments, 
we propose a method that aims to reduce the inter-experiment deviation by fitting all experiments to one reference 
experiment. Our approach is based on the central assumption that we have a constant set of measures for all experi-
ments with comparable measurement distributions. In this case, all deviations of the measure can be directly related 
to other sources of non-biological heterogeneity in data acquisition. In our experimental setup, we have for each 
experiment cells incubated at 37 °C with no radiation applied at the first time point, for which we assumed similar 
distributions. In the following example, we also assumed equal cell numbers in all experiments. This was not the case 
in our data sets, which required us to employ additional interpolation or extrapolation steps.
Example of normalization procedure. Let Eijk be the set of our experimental measures, with i the experiment, j 
the time point and a cell k. We assume that all experiments have the same experimental condition at time point 
j = 1 and we set one experiment x as the reference. To fit another experiment y to the experiment x we use the 
following computation. The central part is the estimation of the coefficients weight. We start by computing the 
coefficient by weight = sort(E(x,1,:))./sort(E(y,1,:)). In the next steps we use the weight to fit the experiment y onto 
x by applying the coefficient to each time point.
The idea is that the non-biological error is constant over time and that we can estimate the error at the time 
point where we can assume identical conditions. In Supplement Fig. 1 we present some results of this normali-
zation method. The presented data demonstrates that temporal dynamics and differences in the strength of the 
response are conserved after normalization among the different experimental conditions. This method gives us 
the opportunity to directly compare normalized measures of the abundance of p53 within the cell populations.
Pitch detection - Average Magnitude Difference Function (AMDF). Among the different pitch 
detection algorithms AMDF is the most commonly used. AMDF, a variation on autocorrelation analysis, was 
proposed by Ross et al. in 197462 and is used for real time applications as it involves less computational effort83. 
We used window lengths between 4.5 h - 7 h and assumed a pitch period lower bound of 2 h. For robustness we 
computed the different pitch positions for the different window sizes and used the mean of overall window sizes 
for a certain pitch position.
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Feature detection. The aim of feature detection is the identification of patterns in time series data. In gen-
eral, we aim to find pulses in our data. However, our approach is not limited in the kind of pattern we like to 
identify in the data, which can have any more or less complicated form.
The proposed method works in a two-step approach. First we normalize each trajectory using a band based on 
local minima and maxima (Suppl. Fig. 2B,C) followed by the detection itself that is based on a Smith-Waterman65 
like version of the dynamic time warping64 approach. In the following we will describe both steps in detail.
The band normalization computes at the begin constants based on the time series data that are used for gen-
erating a band around each trajectory. These constants define different attributes of the bands like the width, a 
maximum value for the lower bound and a minimal level of the upper bound. Using these constants and anchors 
for the past and the future, we estimate for each trajectory a band, as shown in Suppl. Fig. 2B. The anchors are sim-
ple extensions of the trajectory. We than used the band to normalize the trajectory by subtracting for each time 
point the lower bound from the measured value and the upper bound and afterward divide the reduced value of 
the measure by the reduced value of the upper bound. This normalizes the trajectories to a fixed range between 0 
and 1, (Suppl. Fig. 2C). The idea of band normalisation is to emphasise fluctuations at a longer temporal scale in 
the data, which is is necessary for the next step to work properly.
In the following feature detection step, we apply an adjusted dynamic time warping approach to find appear-
ances of a symmetric peak pattern in the range 0–1 of length 4 h. In other applications of the method, this pattern 
can have a completely different shape appropriate for the specific demands. To find the defined pattern, first we 
initiated the scoring matrix as described in the literature64 except for the fact that the pattern can start and end 
at every position in the trajectory. This can simply be achieved by putting zeros at the first column of the scoring 
matrix and infinite into the upper row (assuming the columns correspond the values in the patter) at the initiation 
step. After filling the scoring matrix, we find the beginnings and ends of pattern occurrences by backtracking 
from the local minima in the last column. To improve the result, we afterwards filter overlapping occurrences.
Having the start and the end points of pulses we can straightforward extract several features (Suppl. Fig. 2A) 
of the different patterns. Suppl. Fig. 2D shows the identified pulses in a false colour representation sorted by the 
length of the time the first detected pulse ended.
Image processing Fig. 5C,D. To enhance small pulses especially in the non-irradiated scenario, we have 
applied image processing techniques. First we sorted the trajectories according to the length of the first detected 
pulse after the temperature was reduced from the shortest to the longest. Then we applied a Gaussian filter 
(11 × 11) on the data matrix of the sorted time series data. On the filtered result we applied an additional median 
filter (31 × 31). We used the difference between the two filtered data matrices to enhance the pulses in the data as 
shown in Fig. 5C,D.
Reverse transcriptase quantitative PCR. We extracted mRNA using High Pure RNA Isolation kits 
(Roche, Mannheim, Germany). cDNA was generated using ProtoScript reverse transcriptase (NEB, Ipswich, MA) 
and oligo-dT primers. Quantitative PCR was performed in triplicate using SYBR Green reagent (Roche, Basel) 
on a StepOnePlus PCR machine (Thermo Fisher Scientific, Darmstadt). Primer sequences were as follows: BAX 
forward, CTG ACG GCA ACT TCA ACT GG; BAX reverse, GAT CAG TTC CGG CAC CTT GG; GADD45 
forward, GCA ATA TGA CTT TGG AGG AAT TCT C; GADD45 reverse, TGA CTC AGG GCT TTG CTG; 
XPC forward, GTC TCT ACA GCC AAT TCC TCT G; XPC reverse, CCT TTG CTG GTC TTT GGT TTG; p21 
forward, TGG ACC TGT CAC TGT CTT GT and p21 reverse, TCC TGT GGG CGG ATT AG.
Flow cytometry. Cells were plated in 6 cm dishes two days before experiments. Cells were exposed to 10 Gy 
X-ray radiation, harvested at indicated time points by trypsination, washed with 1xPBS, fixed with ice-cold 80% 
Ethanol/20% 1xPBS and stored at −20 °C until all samples were collected. For flow cytometry analysis, cells were 
washed with 1xPBS, stained with 25 mg/ml PI in 0.1% Triton 1xPBS with 0.2 mg/ml RNase A and analyzed on a 
Cytomics FC500 cytometer (Beckman Coulter). Cell cycle phases were determined based on the DNA content in 
FlowJo software (FlowJo, LLC).
Data availability
Matlab (Mathworks) was used to analyses and process data. Time series data of all tracked cells as well as data 
analysis scripts are available online (https://doi.org/10.25534/tudatalib-34). Original image data and image 
analysis scripts are available from the corresponding author upon reasonable request.
Received: 25 March 2019; Accepted: 13 January 2020;
Published: xx xx xxxx
1 2Scientific RepoRtS |         (2020) 10:1481  | https://doi.org/10.1038/s41598-020-58267-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
References
 1. Hastings, J. W. & Sweeney, B. M. On the mechanism of temperature independence in a biological clock. Proc. Natl. Acad. Sci. USA 
43, 804–11 (1957).
 2. Harper, C. V. et al. Temperature regulates NF-κB dynamics and function through timing of A20 transcription. Proc. Natl. Acad. Sci. 
USA 115, E5243–E5249 (2018).
 3. Fischer, M. Census and evaluation of p53 target genes. Oncogene 36, 3943–3956 (2017).
 4. Fischer, M., Steiner, L. & Engeland, K. The transcription factor p53: not a repressor, solely an activator. Cell Cycle 13, 3037–3058 
(2014).
 5. Pei, D., Zhang, Y. & Zheng, J. Regulation of p53: a collaboration between Mdm2 and MdmX. Oncotarget 3, 228–235 (2012).
 6. Levine, A. J. & Oren, M. The first 30 years of p53: growing ever more complex. Nat. Rev. Cancer 9(no. 10), 749–758 (2009).
 7. Marcel, V., Nguyen Van Long, F. & Diaz, J.-J. 40 Years of Research Put p53 in Translation. Cancers (Basel). 10 (2018).
 8. Batchelor, E., Loewer, A., Mock, C. & Lahav, G. Stimulus-dependent dynamics of p53 in single cells. Mol Syst Biol 7, 488–488 (2011).
 9. Lahav, G. et al. Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet. 36, 147–150 (2004).
 10. Purvis, J. E. & Lahav, G. Encoding and decoding cellular information through signaling dynamics. Cell 152, 945–956 (2013).
 11. Geva-Zatorsky, N. et al. Oscillations and variability in the p53 system. Mol. Syst. Biol. 2 (2006).
 12. Batchelor, E., Loewer, A. & Lahav, G. The ups and downs of p53: understanding protein dynamics in single cells. Nat. Rev. Cancer 9, 
371–377 (2009).
 13. Shadfan, M., Lopez-Pajares, V. & Yuan, Z.-M. MDM2 and MDMX: Alone and together in regulation of p53. Transl. Cancer Res. 1, 
88–89 (2012).
 14. Borcherds, W. et al. Disorder and residual helicity alter p53-Mdm2 binding affinity and signaling in cells. Nat. Chem. Biol. 10, 
1000–1002 (2014).
 15. Purvis, J. E. et al. p53 dynamics control cell fate. Science 336, 1440–4 (2012).
 16. Muller, P. A. J. & Vousden, K. H. p53 mutations in cancer. Oncogene 15 (2013).
 17. Gurpinar, E. & Vousden, K. H. Hitting cancers’ weak spots: Vulnerabilities imposed by p53 mutation. Trends in Cell Biology 25, 
486–495 (2015).
 18. Sund-Levander, M., Forsberg, C. & Wahren, L. K. Normal oral, rectal, tympanic and axillary body temperature in adult men and 
women: a systematic literature review. Scand. J. Caring Sci. 16, 122–128 (2002).
 19. Gisolfi, C. V. & Mora, F. (Mora T. The hot brain: survival, temperature, and the human body. (MIT Press, 2000).
 20. Nakamura, K. Central circuitries for body temperature regulation and fever. Am. J. Physiol. Integr. Comp. Physiol. 301, R1207–R1228 
(2011).
 21. Byrne, C. & Lim, C. L. The ingestible telemetric body core temperature sensor: a review of validity and exercise applications. Br. J. 
Sports Med. 41, 126–33 (2007).
 22. Lim, C. L., Byrne, C. & Lee, J. K. Human thermoregulation and measurement of body temperature in exercise and clinical settings. 
Ann. Acad. Med. Singapore 37, 347–53 (2008).
 23. Guilherme, L. & Kalil, J. Rheumatic Fever and Rheumatic Heart Disease: Cellular Mechanisms Leading Autoimmune Reactivity and 
Disease. J. Clin. Immunol. 30, 17–23 (2010).
 24. Mahadevan, S. V. & Garmel, G. M. An introduction to clinical emergency medicine. (Cambridge University Press, 2005).
 25. Holleman, A. F., Wiberg, E. & Wiberg, N. Anorganische ChemienBand 1, Grundlagen und Hauptgruppenelemente.
 26. Ó’Fágáin, C. Enzyme stabilization—recent experimental progress. Enzyme Microb. Technol. 33, 137–149 (2003).
 27. Engin, K. Biological rationale and clinical experience with hyperthermia. Control. Clin. Trials 17, 316–342 (1996).
 28. Luchetti, F., Canonico, B., Burattini, S. & Papa, S. Hyperthermia triggers apoptosis and affects cell adhesiveness in human 
neuroblastoma cells. Artic. Histol. Histopathol. https://doi.org/10.14670/HH-18.1041 (2003).
 29. Lepock, J. R. Role of nuclear protein denaturation and aggregation in thermal radiosensitization. Int. J. Hyperth. 20, 115–130 (2004).
 30. Vertrees, R. A. et al. A mechanism of hyperthermia-induced apoptosis in ras-transformed lung cells. Mol. Carcinog. 44, 111–121 
(2005).
 31. Roti Roti, J. L. Cellular responses to hyperthermia (40–46 °C): Cell killing and molecular events. Int. J. Hyperth. 24, 3–15 (2008).
 32. Moran, D. S. & Mendal, L. Core Temperature Measurement. Sport. Med. 32, 879–885 (2002).
 33. Maréchal, A. & Zou, L. DNA damage sensing by the ATM and ATR kinases. Cold Spring Harb. Perspect. Biol. 5, a012716 (2013).
 34. Furusawa, Y. et al. Inhibition of checkpoint kinase 1 abrogates G2/M checkpoint activation and promotes apoptosis under heat 
stress. Apoptosis 17, 102–112 (2012).
 35. Turner, T. & Caspari, T. When heat casts a spell on the DNA damage checkpoints. Open Biol. 4, 140008–140008 (2014).
 36. Hunt, C. R. et al. Hyperthermia Activates a Subset of Ataxia-Telangiectasia Mutated Effectors Independent of DNA Strand Breaks 
and Heat Shock Protein 70 Status. Cancer Res. 67, 3010–3017 (2007).
 37. Seno, J. D. & Dynlacht, J. R. Intracellular redistribution and modification of proteins of the Mre11/Rad50/Nbs1 DNA repair complex 
following irradiation and heat-shock. J. Cell. Physiol. 199, 157–170 (2004).
 38. Laszlo, A. & Fleischer, I. Heat-Induced Perturbations of DNA Damage Signaling Pathways are Modulated by Molecular Chaperones. 
Cancer Res. 69, 2042–2049 (2009).
 39. Mantso, T. et al. Effects of hyperthermia as a mitigation strategy in DNA damage-based cancer therapies. Semin. Cancer Biol. 37–38, 
96–105 (2016).
 40. Hehr, T., Wust, P., Bamberg, M. & Budach, W. Current and Potential Role of Thermoradiotherapy for Solid Tumours. Oncol. Res. 
Treat. 26, 295–302 (2003).
 41. Lutgens, L. et al. Combined use of hyperthermia and radiation therapy for treating locally advanced cervical carcinoma. In Cochrane 
Database of Systematic Reviews https://doi.org/10.1002/14651858.cd006377.pub2. (John Wiley & Sons, Ltd, 2010).
 42. Neulander, E. Z. & Kaneti, J. LONG-term outcomes of a randomized controlled trial comparing thermochemotherapy with 
mitomycin-C alone as adjuvant treatment for non-muscle-invasive bladder cancer (NMIBC). BJU International 107, 1685 (2011).
 43. Robinson, J. E., Wizenberg, M. J. & Mccready, W. A. Combined hyperthermia and radiation suggest an alternative to heavy particle 
therapy for reduced oxygen enhancement ratios. Nature 251, 521–522 (1974).
 44. Gerner, E. W. et al. The Potential of Localized Heating as an Adjunct to Radiation Therapy. Radiology 116, 433–439 (1975).
 45. Weinstein, J. N., Magin, R. L., Cysyk, R. L. & Zaharko, D. S. Treatment of solid L1210 murine tumors with local hyperthermia and 
temperature-sensitive liposomes containing methotrexate. Cancer Res. 40, 1388–95 (1980).
 46. Ba, M.-C. et al. Mild hyperthermia enhances sensitivity of gastric cancer cells to chemotherapy through reactive oxygen 
species–induced autophagic death. Tumor Biol. 39, 101042831771195 (2017).
 47. Hildebrandt, B. et al. The cellular and molecular basis of hyperthermia. Crit. Rev. Oncol. Hematol. 43, 33–56 (2002).
 48. Ohnishi, T. The role of the p53 molecule in cancer therapies with radiation and/or hyperthermia. Journal of Cancer Research and 
Therapeutics 1, 147–150 (2005).
 49. Bhuyan, B. Kinetics of cell kill by hyperthermia. Cancer Res. 39, 2277–84 (1979).
 50. Saladino, C. & Ben-Hur, E. Heat-enhanced radioresponse in HeLa cells. Isr. J. Med. Sci. 12, 134–38 (1976).
 51. Corry, P. M., Robinson, S. & Getz, S. Hyperthermic Effects on DNA Repair Mechanisms. Radiology 123, 475–482 (1977).
 52. Anckar, J. & Sistonen, L. Heat Shock Factor 1 as a Coordinator of Stress and Developmental Pathways. In Molecular Aspects of the 
Stress Response: Chaperones, Membranes and Networks 594, 78–88 (Springer New York, 2007).
13Scientific RepoRtS |         (2020) 10:1481  | https://doi.org/10.1038/s41598-020-58267-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
 53. Widłak, P., Gramatyka, M. & Kimmel, M. Crosstalk between stress-induced NF-κB, p53 and HSF1 signaling pathways – review. 
IFAC Proc. 47, 11518–11523 (2014).
 54. Oda, T. et al. Acute HSF1 depletion induces cellular senescence through the MDM2-p53-p21 pathway in human diploid fibroblasts. 
J. Cell Sci. 131, jcs210724 (2018).
 55. Logan, I. R. et al. Heat shock factor-1 modulates p53 activity in the transcriptional response to DNA damage. Nucleic Acids Res. 37, 
2962–2973 (2009).
 56. Müller, L., Schaupp, A., Walerych, D., Wegele, H. & Buchner, J. Hsp90 Regulates the Activity of Wild Type p53 under Physiological 
and Elevated Temperatures. J. Biol. Chem. 279, 48846–48854 (2004).
 57. Walerych, D. et al. Hsp70 molecular chaperones are required to support p53 tumor suppressor activity under stress conditions. 
Oncogene 28, 4284–4294 (2009).
 58. Zylicz, M., King, F. W. & Wawrzynow, A. Hsp70 interactions with the p53 tumour suppressor protein. EMBO J. 20, 4634–4638 
(2001).
 59. Finzel, A., Grybowski, A., Strasen, J., Cristiano, E. & Loewer, A. Hyperactivation of ATM upon DNA-PKcs inhibition modulates p53 
dynamics and cell fate in response to DNA damage. Mol. Biol. Cell 27, 2360–7 (2016).
 60. Moenke, G. et al. Excitability in the p53 network mediates robust signaling with tunable activation thresholds in single cells. bioRxiv 
(2016).
 61. Sheng, C. et al. PCNA-Mediated Degradation of p21 Coordinates the DNA Damage Response and Cell Cycle Regulation in 
Individual Cells. Cell Rep. 27, 48–58.e7 (2019).
 62. Ross, M., Shaffer, H., Cohen, A., Freudberg, R. & Manley, H. Average magnitude difference function pitch extractor. IEEE Trans. 
Acoust. 22, 353–362 (1974).
 63. Reyes, B. A., Pendergast, J. S. & Yamazaki, S. Mammalian peripheral circadian oscillators are temperature compensated. Journal of 
Biological Rhythms 23, 95–98 (2008).
 64. Vintsyuk, T. K. Speech discrimination by dynamic programming. Cybernetics 4, 52–57 (1972).
 65. Smith, T. F. & Waterman, M. S. Identification of common molecular subsequences. J. Mol. Biol. 147, 195–7 (1981).
 66. Purvis, J. E. et al. p53 Dynamics Control Cell Fate. Science (80-.). 336, 1440–1444 (2012).
 67. Joerger, A. C. & Fersht, A. R. The p53 Pathway: Origins, Inactivation in Cancer, and Emerging Therapeutic Approaches. Annu. Rev. 
Biochem. 85, 375–404 (2016).
 68. Joerger, A. C. & Fersht, A. R. Structural Biology of the Tumor Suppressor p53 and Cancer‐Associated Mutants. Adv. Cancer Res. 97, 
1–23 (2007).
 69. Peng, Y., Chen, L., Li, C., Lu, W. & Chen, J. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization. J. Biol. Chem. 276, 
40583–90 (2001).
 70. Li, D. et al. Functional Inactivation of Endogenous MDM2 and CHIP by HSP90 Causes Aberrant Stabilization of Mutant p53 in 
Human Cancer Cells. Mol. Cancer Res. 9, 577–588 (2011).
 71. Vitale, I., Galluzzi, L., Castedo, M. & Kroemer, G. Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat. Rev. Mol. 
Cell Biol. 12, 385–392 (2011).
 72. Soares, I. P. et al. Application of Hyperthermia for Cancer Treatment: Recent Patents Review. Recent Pat. Anticancer. Drug Discov. 7, 
64–73 (2012).
 73. Rao, W., Deng, Z.-S. & Liu, J. A Review of Hyperthermia Combined With Radiotherapy/Chemotherapy on Malignant Tumors. Crit. 
Rev. Biomed. Eng. 38, 101–116 (2010).
 74. Ota, I. et al. Therapeutic strategies for head and neck cancer based on p53 status. Exp. Ther. Med. 3, 585–591 (2012).
 75. Sakakura, C. et al. Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, 
hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers. Br. J. Cancer 77, 159–166 (1998).
 76. Ohnstad, H. O. et al. Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma. Cancer 119, 1013–1022 
(2013).
 77. Le Guellec, S. et al. Are Peripheral Purely Undifferentiated Pleomorphic Sarcomas With MDM2 Amplification Dedifferentiated 
Liposarcomas? Am. J. Surg. Pathol. 38, 293–304 (2014).
 78. Kinuya, S. et al. Optimal Timing of Administration of Hyperthermia in Combined Radioimmunotherapy. Cancer Biother. 
Radiopharm. 15, 373–379 (2000).
 79. Hauck, M. L. & Zalutsky, M. R. Enhanced tumour uptake of radiolabelled antibodies by hyperthermia: Part I: Timing of injection 
relative to hyperthermia. Int. J. Hyperth. 21, 1–11 (2005).
 80. Cohen, A. A. et al. Dynamic proteomics of individual cancer cells in response to a drug. Science (80-.). 322 (2008).
 81. Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 
(2006).
 82. Strasen, J. et al. Cell-specific responses to the cytokine TGF$β$ are determined by variability in protein levels. Mol. Syst. Biol. 14, 
1744–4292 (2018).
 83. Muhammad, G. Extended Average Magnitude Difference Function Based Pitch Detection. The International Arab Journal of 
Information Technology 8 (2011).
Acknowledgements
This work was supported by German Cancer Aid (project number 111645 to A.L.). We acknowledge support by 
the German Research Foundation and the Open Access Publishing Fund of Technische Universität Darmstadt.
Author contributions
Investigation, P.S. and E.C.; Experimental tools, C.S.; Methodology, Software, Formal analysis, Data curation, 
M.J.; Visualization, Writing – original draft, M.J. and A.L.; Writing – Review & Editing, P.S., M.J., A.L.; 
Conceptualization, Supervision– A.L.
Competing interests
The authors declare no competing interests.
Additional information
Supplementary information is available for this paper at https://doi.org/10.1038/s41598-020-58267-1.
Correspondence and requests for materials should be addressed to A.L.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
1 4Scientific RepoRtS |         (2020) 10:1481  | https://doi.org/10.1038/s41598-020-58267-1
www.nature.com/scientificreportswww.nature.com/scientificreports/
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2020
